163 related articles for article (PubMed ID: 33646306)
1. Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.
Iglesias P; Puller AC; Seoane M; Spohn M; Raasch S; Klokow M; Müller J; Burkhardt L; Indenbirken D; Horstmann MA
Blood Adv; 2021 Mar; 5(5):1209-1223. PubMed ID: 33646306
[TBL] [Abstract][Full Text] [Related]
2. ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.
Mesuraca M; Chiarella E; Scicchitano S; Codispoti B; Giordano M; Nappo G; Bond HM; Morrone G
Biomed Res Int; 2015; 2015():165238. PubMed ID: 26788497
[TBL] [Abstract][Full Text] [Related]
3. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.
Harder L; Eschenburg G; Zech A; Kriebitzsch N; Otto B; Streichert T; Behlich AS; Dierck K; Klingler B; Hansen A; Stanulla M; Zimmermann M; Kremmer E; Stocking C; Horstmann MA
J Exp Med; 2013 Oct; 210(11):2289-304. PubMed ID: 24081948
[TBL] [Abstract][Full Text] [Related]
4. ZNF423: Transcriptional modulation in development and cancer.
Harder L; Puller AC; Horstmann MA
Mol Cell Oncol; 2014; 1(3):e969655. PubMed ID: 27308357
[TBL] [Abstract][Full Text] [Related]
5. Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming.
Boller S; Ramamoorthy S; Akbas D; Nechanitzky R; Burger L; Murr R; Schübeler D; Grosschedl R
Immunity; 2016 Mar; 44(3):527-541. PubMed ID: 26982363
[TBL] [Abstract][Full Text] [Related]
6. Interaction of CCR4-NOT with EBF1 regulates gene-specific transcription and mRNA stability in B lymphopoiesis.
Yang CY; Ramamoorthy S; Boller S; Rosenbaum M; Rodriguez Gil A; Mittler G; Imai Y; Kuba K; Grosschedl R
Genes Dev; 2016 Oct; 30(20):2310-2324. PubMed ID: 27807034
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.
Miyazaki K; Yamasaki N; Oda H; Kuwata T; Kanno Y; Miyazaki M; Komeno Y; Kitaura J; Honda Z; Warming S; Jenkins NA; Copeland NG; Kitamura T; Nakamura T; Honda H
Blood; 2009 May; 113(19):4702-10. PubMed ID: 19234145
[TBL] [Abstract][Full Text] [Related]
8. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
[TBL] [Abstract][Full Text] [Related]
9. B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1.
Hagman J; Ramírez J; Lukin K
Curr Top Microbiol Immunol; 2012; 356():17-38. PubMed ID: 21735360
[TBL] [Abstract][Full Text] [Related]
10. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.
Györy I; Boller S; Nechanitzky R; Mandel E; Pott S; Liu E; Grosschedl R
Genes Dev; 2012 Apr; 26(7):668-82. PubMed ID: 22431510
[TBL] [Abstract][Full Text] [Related]
12. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
[TBL] [Abstract][Full Text] [Related]
13. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
14. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes.
Lukin K; Fields S; Guerrettaz L; Straign D; Rodriguez V; Zandi S; Månsson R; Cambier JC; Sigvardsson M; Hagman J
Eur J Immunol; 2011 Jun; 41(6):1787-93. PubMed ID: 21469119
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.
Teppo S; Laukkanen S; Liuksiala T; Nordlund J; Oittinen M; Teittinen K; Grönroos T; St-Onge P; Sinnett D; Syvänen AC; Nykter M; Viiri K; Heinäniemi M; Lohi O
Genome Res; 2016 Nov; 26(11):1468-1477. PubMed ID: 27620872
[TBL] [Abstract][Full Text] [Related]
16. C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.
Barberi T; Cui C; Friedman AD
PLoS One; 2020; 15(12):e0244161. PubMed ID: 33332417
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Proteomic Investigation of Ebf1 Heterozygosity in Pro-B Lymphocytes Utilizing Data Independent Acquisition.
Musa YR; Boller S; Puchalska M; Grosschedl R; Mittler G
J Proteome Res; 2018 Jan; 17(1):76-85. PubMed ID: 29181981
[TBL] [Abstract][Full Text] [Related]
18. The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function.
Boller S; Grosschedl R
Immunol Rev; 2014 Sep; 261(1):102-15. PubMed ID: 25123279
[TBL] [Abstract][Full Text] [Related]
19. STAT5 in B cell development and leukemia.
Malin S; McManus S; Busslinger M
Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
[TBL] [Abstract][Full Text] [Related]
20. Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis.
Li J; Bhattacharya S; Zhou J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
J Immunol; 2017 Nov; 199(10):3504-3515. PubMed ID: 28978690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
